Trade Summary

4 days ago, Zoon Kathryn C, serving as Dir at Emergent Biosolutions Inc. (EBS), sold 17,202 shares at $8.40 per share, for a total transaction value of $144,453.00. Following this transaction, Zoon Kathryn C now holds 79,941 shares of EBS.

This sale represents a 18.00% decrease in Zoon Kathryn C's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, May 1, 2026 and publicly disclosed via SEC Form 4 filing on Monday, May 4, 2026, 3 days after the trade was made.

Emergent Biosolutions Inc. operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.